X-ZELL Blog Episode 5

Episode 5 MRI's role in prostate cancer screening The role of magnetic resonance imaging (MRI) as a tool to detect and stage clinically significant prostate cancer (csPCa) continues to cause controversy among the medical community.The 19th Asia-Pacific Prostate Cancer...

X-ZELL Blog Episode 4

Episode 4 A new way to avoid painful prostate biopsies Friday, 24 August 2018, will go down as a decisive milestone in the history of X-ZELL Inc. – not just because we had the privilege of sharing our latest research with the global scientific community, but also...

X-ZELL Blog Episode 3

Episode 3 Explained: The early detection paradox Even though the notion of discovering prostate cancer early may seem intriguing from a patient perspective, the topic has been dividing the medical community for decades. The sticking point is a simple question – how...

X-ZELL Blog Episode 2

Episode 2 The biotech dilemma Last month, X-ZELL CEO, Dr Sebastian Bhakdi, used his guest speaking spot at the 2018 HealthInvestor Asia Summit to reflect on the opportunities and challenges biotechnology start-ups face in Asia – revealing why so many of them fail to...

X-ZELL Blog Episode 1

Episode 1 Are we serious about prostate health? Often underestimated, prostate cancer continues to be a significant threat to men’s health. An estimated 1.1 million men worldwide are diagnosed with the disease every year, some 400,000 die of it. That’s about 45 men...